ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010

In Brief: Transition Team Denies It Is Seeking New NCI Director; Garb Undergoes Surgery At M.D.A

November 28, 1980

Greenpeace Report Says Chemicals Causing Breast Cancers

October 22, 1993

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977

New Saccharin Studies Convince FDA It A Carcinogen

July 15, 1977

MSKCC Asked To Repay $638,371 To NIH

December 13, 1985